
The ‘Godzilla’ of Weight Loss Drugs Could Take ‘Ozempic Face’ to the Extreme
By Roosa Rahkonen
From sunken under-eyes to hollow temples and loose skin, many people using weight-loss drugs report dramatic side effects on their appearance. Now, experts say an upcoming weight-loss drug could make these unwanted facial changes even more striking. Eli Lilly, the company behind weight-loss medication Zepbound and type 2 diabetes medication Mounjaro, is reportedly developing a new drug already…
This story was published by The Daily Beast. Read the full article on their site.
Read the full story at thedailybeast.com(opens in a new tab)






